A system, method, and processor-readable medium are provided for quantitatively evaluating risk associated with nanotechnology. An insurance company computing system obtains nanomaterial-related data from a variety of sources, including nanomaterial sensors such as differential mobility analyzers located on-site at an insured facility. The insurance computing system uses the obtained data and a computerized model to compute a risk score that is used in evaluating the insurability of the facility or the operating entity. An insurance policy or modifications to an existing insurance premium are subsequently produced based on the computed risk score.

 
Web www.patentalert.com

< Merocyanine derivatives for cosmetic use

> Compositions containing phenethyl aryl esters as solubilizing agents for active organic compounds

> Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)

~ 00577